{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-013881","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2025-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.678172+00:00","generated_at":"2026-05-17T06:20:35.269002+00:00","sec_items":["1.01","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NanoVibronix prices $2M registered direct offering of common stock and prefunded warrants at $7.01","bullets":["Offering of 74,114 common shares and prefunded warrants for 217,090 shares at $7.01 per share (or $7.009 per warrant).","Gross proceeds of ~$2.0M; net proceeds ~$1.8M after placement fees and expenses.","Proceeds to be used for working capital, repayment of debt and/or redemption of preferred stock.","Palladium Capital Group acted as exclusive placement agent; closing expected September 17, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-013881","json":"https://secwatch.observer/filing/0001493152-25-013881.json","markdown":"https://secwatch.observer/filing/0001493152-25-013881.md","text":"https://secwatch.observer/filing/0001493152-25-013881.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225013881/0001493152-25-013881-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225013881/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:20:35.269002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}